Últimas noticias sobre Citius Oncology (NASDAQ:CTOR) Bolsa

Citius Oncology

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Citius Oncology Inc

Scotiabank analyst Meny Grauman downgrades iA Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IAG#TSX">IAG</a>) from Sector Outperform to Sector Perform and announces C$143 price target.

News

Downgrades

Price Target

Analyst Ratings

TSX:IAG

Scotiabank Downgrades iA Financial to Sector Perform, Announces C$143 Price Target

Contracts

NCR Voyix Awarded $335M Contract With Defense Commissary Agency For DeCA Enterprise Business Operations Solutions

Scotiabank analyst Meny Grauman upgrades Great-West Lifeco (TSX:<a class="ticker" href="https://www.benzinga.com/stock/GWO#TSX">GWO</a>) from Sector Perform to Sector Outperform and raises the price target from C$52 to C$59.

Upgrades

TSX:GWO

Scotiabank Upgrades Great-West Lifeco to Sector Outperform, Raises Price Target to C$59

Morgan Stanley analyst Piyush Sood maintains Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) with a Equal-Weight and lowers the price target from $65 to $56.

Morgan Stanley Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $56

SoundHound AI's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NYSE">SOUN</a>) short percent of float has risen 25.93% since its last report. The company recently reported that it has 100.76 million shares sold short, which is 30.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>SoundHound AI Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738593025_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SoundHound AI has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing SoundHound AI's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, SoundHound AI's peer group average for short interest as a percentage of float is 9.06%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

SOUN

How Is The Market Feeling About SoundHound AI?

Morgan Stanley analyst Carlos De Alba maintains Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) with a Equal-Weight and lowers the price target from $13 to $11.

Morgan Stanley Maintains Equal-Weight on Cleveland-Cliffs, Lowers Price Target to $11

Li Auto's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LI#NYSE">LI</a>) short percent of float has risen 4.37% since its last report. The company recently reported that it has 32.25 million shares sold short, which is 5.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.61 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Li Auto Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738593020_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Li Auto has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Li Auto's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Li Auto's peer group average for short interest as a percentage of float is 7.53%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Li Auto's Recent Short Interest

Tyson Foods Says We Are At The Bottom Of Cattle Cycle, Improved U.S. Pasture Conditions Provide Chance To Increase Herd Size

FuboTV's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) short percent of float has fallen 15.81% since its last report. The company recently reported that it has 33.04 million shares sold short, which is 10.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>FuboTV Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738593013_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for FuboTV has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing FuboTV's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, FuboTV's peer group average for short interest as a percentage of float is 7.03%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FUBO

(FUBO) - Analyzing FuboTV's Short Interest

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 9.45%. Currently, Honeywell Intl has a market capitalization of $143.92 billion. 
Buying $100 In HON: If an investor had bought $100 of HON stock 20 years ago, it would be worth $625.36 today based on a price of $221.34 for HON at the time of writing.
<h3>Honeywell Intl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738593010_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Shares of Liquidity Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>), a prominent player in global commerce focused on the circular economy, are trading lower in <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket trading on Monday.</a>
The company announced&nbsp;the acquisition of Auction Software/Simple Auction Site. Terms of the transaction were not disclosed.
Founded by Rajesh Rajaram in 2015, Auction Software has created auction and marketplace platforms for various industries. Simple Auction Site (SAS) focuses on providing auction platforms for sports collectibles and fine wine.
This move establishes a new private-label and Software-as-a-Service (SaaS) division, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43429957/liquidity-services-acquires-auction-software-a-leading-provider-of-auction-software-and-marketplac" rel="noreferrer noopener">Liquidity Services Software Solutions, Inc</a>.
The acquisition is said to enhance Liquidity Services&#8217; reach in the fragmented Circular Economy market and strengthen its software development resources, enabling the company to better support businesses of all sizes, from entrepreneurs to large multinational corporations.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/01/43395171/walmart-canada-to-invest-about-3-8-billion-over-five-years" rel="noreferrer noopener">Walmart Canada To Invest About $3.8 Billion Over Five Years</a>
&#8220;This acquisition aligns with our commitment to empower organizations to create value in the Circular Economy marketplace using innovative solutions,&#8221; said CEO Bill Angrick.
This acquisition is part of Liquidity Services&#8217; strategy to offer tailored SaaS solutions to a growing client base, including businesses seeking forward, reverse, and hybrid online auctions.
Following the acquisition, Rajesh Rajaram, the founder of Auction Software, along with other key team members, will stay with the company to continue overseeing the development of auction platforms.
The deal is not anticipated to materially affect the overall financial performance of Liquidity Services. The company held $155.5 million in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42456973/liquidity-services-announces-fourth-quarter-fiscal-year-2024-financial-results" rel="noreferrer noopener">cash and equivalents as of September 30, 2024</a>.
Price Action: LQDT shares are trading lower by 7.10% at $34.65 in premarket at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips" target="_blank" rel="noreferrer noopener">Jeep Maker Stellantis Unveils Organizational Overhaul; Stock Dips</a></li>
</ul>
Photo via Shutterstock.

Equities

Movers

General

LQDT

What's Going On With Commerce Company Liquidity Services Stock Today?

Macro Economic Events

Global

Economics

Union Pacific Spokesperson Says We Will Review Any New Tariff Policies And Work With Customers To Provide Solutions That Keep Freight Moving

Guidance

Tyson Foods CEO Donnie King Says Considered Tariff Risks When Raised Earnings Guidance, Does Contingency Planning To Minimize Disruption From Trade Changes

Scotiabank analyst Ben Isaacson maintains West Fraser Timber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFG#NYSE">WFG</a>) with a Sector Outperform and lowers the price target from $120 to $109.

Scotiabank Maintains Sector Outperform on West Fraser Timber, Lowers Price Target to $109

Stephens &amp; Co. analyst Kyle Joseph reiterates OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) with a Overweight and maintains $62 price target.

Reiteration

Stephens & Co. Reiterates Overweight on OneMain Holdings, Maintains $62 Price Target

Russia's Novak Says We Expect Oil Demand To Rise By 1.4M Barrels/Day This Year; We Will Increase Oil Production From April; Russia's Novak On Trump's Comments About Oil Output Increase, Says "This Was Touched Upon"

Morgan Stanley analyst Joseph Moore maintains Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Equal-Weight and raises the price target from $21 to $23.

ALGM

Morgan Stanley Maintains Equal-Weight on Allegro Microsystems, Raises Price Target to $23

WIIM

USDMXN

USD/MXN is higher following US tariffs on Mexico.

Scotiabank analyst Ben Isaacson maintains Western Forest Products (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WEF#TSX">WEF</a>) with a Sector Perform and lowers the price target from C$0.55 to C$0.5.

TSX:WEF

Scotiabank Maintains Sector Perform on Western Forest Products, Lowers Price Target to C$0.5

USDCAD

USD/CAD is higher following US tariffs on Canada.

Citius Oncology (CTOR) just unveiled an update. On August 12, 2024, a notable business combination was finalized, leading to significant changes in...

Citius Oncology Finalizes Merger and Modifies Stock Structure

Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) announced "promising" preliminary results from an ongoing investigator-initiated Phase I c...

Citius Pharmaceuticals, Citius Oncology report promising cancer trial results

Citius Pharmaceuticals reports positive early stage results of cancer combo treatment

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Maxim initiated coverage of Citius Oncology (CTOR) with a Buy rating and $3 price target Published first on TheFly – the ultimate source for real-t...

Citius Oncology  initiated with a Buy at Maxim

D. Boral Capital upgraded Citius Pharmaceuticals (CTXR) to Buy from Hold with a $9 price target. Citius owns 90% of Citius Oncology (CTOR), which i...

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

American Air upgraded, Nordstrom downgraded: Wall Street's top analyst calls

Citius Oncology (CTOR), a majority-owned subsidiary of Citius Pharmaceuticals (CTXR), announced that it has retained Jefferies (JEF) as its exclusi...

Citius Oncology to explore strategic alternatives

Citius Pharmaceuticals (CTXR) and its oncology-focused subsidiary, Citius Oncology (CTOR), announced progress in preparations for the commercial la...

Citius Pharmaceuticals and Citius Oncology to launch Lymphir in 1H25

In a report released yesterday, Michael Okunewitch from Maxim Group maintained a Buy rating on Citius Oncology (CTOR – Research Report), with a pri...

Citius Oncology's Strategic Positioning and Lymphir's Market Launch Drive Buy Rating

ARQT

ARTV

CTOR

CTXR

NAMS

NUVL

ONCY

RAPT

RCKT

Earnings

Press Releases

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors

Comments

Citius Oncology

Noticias

Últimas noticias sobre Citius Oncology (NASDAQ:CTOR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL